500 ICU patients to be tracked in ARDS Real-World study
NCT ID NCT07165717
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will observe 500 people with Acute Respiratory Distress Syndrome (ARDS) in intensive care to understand what factors influence their recovery and survival. Researchers will track deaths, imaging, lab tests, and ventilator use. The goal is to find patterns that could improve care for this serious lung condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict which ARDS patients are at highest risk and improve treatment strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test any new drug or therapy, so direct patient benefits are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fudan University, Zhong Shan Hospital
RECRUITINGShanghai, Shanghai Municipality, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune cell infusion aims to free ARDS patients from ventilators
- New ventilation strategy aims to reduce lung damage in severe pneumonia
- Scientists build a biobank to decode ARDS and personalize treatment
- Scientists hunt for hidden ARDS subtypes to crack deadly lung failure
- Simple chest squeeze may replace High-Tech ventilator settings
- Lab study hopes to unlock ARDS treatment using patient blood cells